Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News HTG Molecular Diagnostics Inc HTGMQ

Healthcare Medical Devices
HTG Molecular Diagnostics, Inc. is a life science company. The Company is focused on advancing precision medicine and drug discovery through its transcriptome-wide profiling and advanced drug discovery platform technologies. The Company is engaged in the sales of its HTG EdgeSeq system and integrated next-generation sequencing-based (NGS-based) HTG EdgeSeq research use only (RUO) assays and... see more

Recent & Breaking News (GREY:HTGMQ)

HTG Molecular Diagnostics Reports Third Quarter 2019 Results

GlobeNewswire November 12, 2019

HTG Molecular Diagnostics to Announce Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12

GlobeNewswire October 31, 2019

HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on Breast Cancer Molecular Diagnostics on October 29

GlobeNewswire October 22, 2019

HTG Announces the Launch of its New Autoimmune Profiling Assay

GlobeNewswire October 15, 2019

HTG Molecular Diagnostics, Inc. Provides Update Regarding Companion Diagnostic Development Programs

GlobeNewswire October 10, 2019

HTG Molecular to Present Corporate Overview at the Cantor 2019 Global Healthcare Conference

GlobeNewswire September 30, 2019

HTG Molecular Diagnostics Announces Completion of $22.5 Million Aggregate Financing, Consisting of $19.0 Million Public Offering of Common Stock, Including the Exercise in Full of the Underwriter's Option to Purchase Additional Shares, and $3.5 Million Concurrent Private Placement

GlobeNewswire September 24, 2019

HTG Molecular Diagnostics Announces Pricing of $20.0 Million Aggregate Financing, Consisting of $16.6 Million Public Offering of Common Stock and $3.5 Million Concurrent Private Placement

Business Wire September 20, 2019

HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock

GlobeNewswire September 19, 2019

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 20, 2019

HTG Molecular Diagnostics Reports Second Quarter 2019 Results

GlobeNewswire August 6, 2019

HTG Molecular to Present Corporate Overview at the Canaccord Genuity 39th Annual Growth Conference

GlobeNewswire July 25, 2019

HTG Molecular Diagnostics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6

GlobeNewswire July 24, 2019

HTG Expands RUO Profiling Menu with New Platform Compatibility Assays

GlobeNewswire July 15, 2019

HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0

GlobeNewswire July 8, 2019

HTG Presents at the 11th Annual Edition of the Worldwide Innovative Networking (WIN) Symposium

GlobeNewswire July 1, 2019

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire May 24, 2019

HTG Molecular Diagnostics Reports First Quarter 2019 Results

GlobeNewswire May 9, 2019

HTG Molecular Diagnostics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9

GlobeNewswire April 30, 2019

HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases

GlobeNewswire April 30, 2019